Westbury, Leo
Bevilacqua, Gregorio
Laskou, Faidra
Kirkham-Wilson, Fiona
Fuggle, Nicholas
Dennison, Elaine
Funding for this research was provided by:
Medical Research Council (MRC_MC_UP_A620_1014)
Medical Research Council (MC_PC_21003)
Medical Research Council (MC_PC_21001)
National Institute for Health and Care Research
Article History
Received: 14 October 2025
Accepted: 5 February 2026
First Online: 19 February 2026
Declarations
:
: The Hertfordshire Research Ethics Committee granted ethical approval (REC reference: 16/LO/1225); all investigations were in accordance with the Declaration of Helsinki and its later amendments or comparable ethical standards.
: Participants gave written informed consent to participate in the study and for their health records to be accessed in the future.
: LW is a member of the Editorial Board for Osteoporosis International. NF is a member of the Editorial Board for Osteoporosis International and reports speaker fees for UCB, Viatris and Amgen, and travel bursaries from Pfizer and Eli Lilly. ED is a member of the Editorial Board for Osteoporosis International and declares consultancy and speaker fees from Pfizer, UCB and Lilly. The remaining authors declare that they have no conflicts of interest.